Cargando…
Mining Data From Plasma Cell Differentiation Identified Novel Genes for Engineering of a Yeast Antibody Factory
Saccharomyces cerevisiae is a common platform for production of therapeutic proteins, but it is not intrinsically suited for the manufacturing of antibodies. Antibodies are naturally produced by plasma cells (PCs) and studies conducted on PC differentiation provide a comprehensive blueprint for the...
Autores principales: | Koskela, Essi V., Gonzalez Salcedo, Alina, Piirainen, Mari A., Iivonen, Heidi A., Salminen, Heidi, Frey, Alexander D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136540/ https://www.ncbi.nlm.nih.gov/pubmed/32296695 http://dx.doi.org/10.3389/fbioe.2020.00255 |
Ejemplares similares
-
Multiplex Genome Engineering Methods for Yeast Cell Factory Development
por: Malcı, Koray, et al.
Publicado: (2020) -
Production of galactosylated complex-type N-glycans in glycoengineered Saccharomyces cerevisiae
por: Piirainen, Mari A., et al.
Publicado: (2021) -
Editorial: Fungi as cell factories: Genetic engineering and applications
por: Billerbeck, Sonja, et al.
Publicado: (2022) -
The Studies in Constructing Yeast Cell Factories for the Production of Fatty Acid Alkyl Esters
por: Zhang, Yang, et al.
Publicado: (2022) -
Biosynthesis of Fatty Alcohols in Engineered Microbial Cell Factories: Advances and Limitations
por: Krishnan, Anagha, et al.
Publicado: (2020)